PL399176A1 - Sposób leczenia otylosci i nadwagi oraz choroby refluksowej zoladkowo-przelykowej - Google Patents

Sposób leczenia otylosci i nadwagi oraz choroby refluksowej zoladkowo-przelykowej

Info

Publication number
PL399176A1
PL399176A1 PL399176A PL39917612A PL399176A1 PL 399176 A1 PL399176 A1 PL 399176A1 PL 399176 A PL399176 A PL 399176A PL 39917612 A PL39917612 A PL 39917612A PL 399176 A1 PL399176 A1 PL 399176A1
Authority
PL
Poland
Prior art keywords
adrc
cells
stomach
overweight
gastric
Prior art date
Application number
PL399176A
Other languages
English (en)
Inventor
Zbigniew Kowalczyk
Original Assignee
Zbigniew Kowalczyk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zbigniew Kowalczyk filed Critical Zbigniew Kowalczyk
Priority to PL399176A priority Critical patent/PL399176A1/pl
Priority to PCT/PL2013/000063 priority patent/WO2013172724A1/en
Publication of PL399176A1 publication Critical patent/PL399176A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sposób leczenia otylosci i nadwagi oraz choroby refleksowej zoladkowo-przelykowej (GERD) polega na tym, ze komórki macierzyste i regeneracyjne wyodrebnione z wlasnej tkanki tluszczowej (ADRC - Adipose Derived Regenerative Cells) wstrzykuje sie w tkanke podsluzowa lub miesniowa, zoladka w okolicach wpustu i dna zoladka. Wyodrebnione komórki ADRC podaje sie w procedurach endoskopowych lub chirurgicznych otwartych lub laparoskopowych. Wyodrebnione komórki ADRC wzbogaca sie dodatkiem graftu tluszczowego w ilosci minimum 5 ml i nie wiecej niz 25 ml. Sposób stanowi uzupelnienie innych procedur bariatrycznych ograniczajacych wielkosc zoladka, jak regulowana opaska zoladkowa, czesciowa resekcja rekawowa zoladka lub wypelniajacych zoladek, jak implanty wewnatrzzoladkowe lub wplywajacych na motoryke albo wywolanie uczucia sytosci poprzez elektrostymulacje (neurostymulatory).
PL399176A 2012-05-14 2012-05-14 Sposób leczenia otylosci i nadwagi oraz choroby refluksowej zoladkowo-przelykowej PL399176A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL399176A PL399176A1 (pl) 2012-05-14 2012-05-14 Sposób leczenia otylosci i nadwagi oraz choroby refluksowej zoladkowo-przelykowej
PCT/PL2013/000063 WO2013172724A1 (en) 2012-05-14 2013-05-14 Method for treating obesity and overweight and gastro-oesophageal reflux disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL399176A PL399176A1 (pl) 2012-05-14 2012-05-14 Sposób leczenia otylosci i nadwagi oraz choroby refluksowej zoladkowo-przelykowej

Publications (1)

Publication Number Publication Date
PL399176A1 true PL399176A1 (pl) 2013-11-25

Family

ID=48949200

Family Applications (1)

Application Number Title Priority Date Filing Date
PL399176A PL399176A1 (pl) 2012-05-14 2012-05-14 Sposób leczenia otylosci i nadwagi oraz choroby refluksowej zoladkowo-przelykowej

Country Status (2)

Country Link
PL (1) PL399176A1 (pl)
WO (1) WO2013172724A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5393119B2 (ja) * 2008-12-05 2014-01-22 日本メナード化粧品株式会社 幹細胞の褐色脂肪細胞への分化誘導方法
US20100160995A1 (en) 2008-12-18 2010-06-24 Jerome Dargent Method for treating obesity
SG194930A1 (en) * 2011-05-19 2013-12-30 Mesoblast Inc Methods for treating obesity and/or metabolic syndrome
ES2803499T3 (es) * 2011-06-29 2021-01-27 Biorestorative Therapies Inc Composiciones y métodos de células grasas marrones

Also Published As

Publication number Publication date
WO2013172724A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
US20110295286A1 (en) Methods and devices for regulating the activation of ghrelin hormones within a stomach
Staudenmann et al. Endoscopic bariatric therapies for obesity: a review
Mathus-Vliegen The cooperation between endoscopists and surgeons in treating complications of bariatric surgery
Abbas et al. Another Petersen’s space hernia after one anastomosis gastric bypass: a video case report
US20110295179A1 (en) Methods and devices for regulating the activation of ghrelin hormones within a stomach
Buhmann et al. Operative strategies for patients with failed primary bariatric procedures
Sawicka-Pierko et al. Gastric band migration to gastrointestinal lumen and possibilities of its surgical treatment.
PL399176A1 (pl) Sposób leczenia otylosci i nadwagi oraz choroby refluksowej zoladkowo-przelykowej
Alamoudi Long-term pulmonary complications after laparoscopic adjustable gastric banding
CN105451692B (zh) 用于可勘探胃部胃旁路的设备
RU2479266C1 (ru) Способ лапароскопического хирургического лечения ожирения
Sundbom et al. Bariatric surgery
Toouli et al. M1255 Intra-Abdominal Vagal Blocking Reduces Calorie Intake, Enhances Satiation and Reduces Hunger During Significant and Sustained Weight Loss in Obese Subjects
US20240307204A1 (en) Method of augmenting weight loss by pylorus-sparing gastric myotomy
RU2714078C1 (ru) Хирургический способ снижения избыточного веса тела человека
Polat et al. Outcome of 232 morbidly obese patients treated with laparoscopic adjustable gastric banding between 1995–2003
Neichoy et al. The Texas experience of stomach intestinal pylorus sparing surgery (SIPS) at one year
Thomusch History of obesity and metabolic surgery
Arroyo et al. Magenstrasse and Mill gastroplasty and sleeve gastrectomy as treatment for morbid obesity.
Lange et al. Efficacy of IV acetaminophen in laparoscopic roux-En-Y gastric bypass surgery patients
Garcíacaballero et al. Revision surgery for one anastomosis gastric bypass with anti-reflux mechanism: a new surgical procedure using only not previously operated intestine
Kerrigan et al. Bariatric surgery
Swartz et al. Overview of bariatric operations
RU2532523C1 (ru) Способ формирования гастроэнтероанастомоза при субтотальной резекции желудка
Felinski et al. Robotic Revision: Mini-gastric bypass to Roux-en-Y gastric bypass